STEP 1
An Ecological Utilitarian Developer
"For the Earth, For My Family, For Myself"
Nam Wooyoung
Development Process
Hello, I am the developer Nam Woo-Young. Before I begin sharing my story. My older brother, Dr. Nam Sang-Min, is a climate change expert serving as the Co-Chair of the UN agency network for climate goals in the Asia-Pacific region and the Director of the UNESCAP Environment and Development Division. Inspired by his influence, I developed a deep interest in global climate and environmental issues starting in 2005, when the Kyoto Protocol came into effect. I majored in computer science and later taught at a university, sharing knowledge with students. However, after losing my health while teaching, I started independent research connecting climate issues with human health.
Throughout my research journey, I had the opportunity to meet many remarkable individuals, including former Minister of Agriculture Kim Seong-Hoon and Nobel Laureate Dr. Svante Pääbo. Through exchanges with these experts, I developed a hypothesis regarding the genetic relationships between plant cells, microorganisms, and human cells. In 2013, I started researching exogenous miRNA in secondary structures, which led to the concept of the Green Red Bio Metabolome. To industrialize this concept, I independently developed the VPMI technology.
As my research gained attention, many terminally ill patients expressed interest in participating in clinical trials. This experience greatly contributed to the development of a more universal and powerful Green Red Bio Metabolome. To date, my research has primarily been funded by myself, conducted independently, and supported by self-managed clinical trials.
Now, I wish to share new knowledge with all of you and work towards a better future. I hope my story can inspire you.
STEP 2
From 2006 to 2009, a hypothesis was developed and researched on genetic interactions among plants, microbes, and the human body.
In 2010, salt-free plant-based fermented food using 32 types of plants was developed, and a successful clinical case with the developer’s terminally ill mother demonstrated restoration of cellular health, validating the technology’s effectiveness.
Between 2014 and 2016, research confirmed that genetic interactions between plant cells and microorganisms could produce beneficial substances such as amino acids, short-chain fatty acids, vitamins, organic acids, and phytochemicals. Additional studies explored the genetic correlations between human intestinal microbiota and human cells, providing deeper insight into the foundations of life.
From 2013 to 2018, the developer conducted extensive voluntary clinical trials targeting a wide demographic—from fetuses to patients in their 90s, including those with terminal-stage cancer (stage IV). These trials were conducted free of charge and received public attention through media coverage. Notably, the trials achieved a remarkable Complete Response (CR) rate of 93.4%, validating the therapeutic potential of the Green Red Bio Metabolome.
Jang Wol-ja (First Clinical Trial Subject: Mother)
After successfully restoring the developer’s mother’s cellular health, efforts focused on creating an industrial process to reduce costs, increase yield, and support a carbon-neutral, climate-adaptive model—leading to the development of the Green-Red Bio Metabolome Platform Technology.
STEP 3
Between 2018 and 2023, Elan Vital Bio successfully developed a 3rd-generation plant-based industrial bio-catalyst (VPMI), designed for large-scale application in the Green Red Bio Metabolome (GRBM) platform. Following this, a full industrial process model was established for GRBM production. Using this model, ten representative GRBM metabolome products were produced, including the Ginseng Green Red Bio Metabolome, and these were effectively used in the treatment of various intractable diseases. In parallel, clinical trials were conducted using innovative injectable formulations based on miRNA and plantaricin, targeting genetic and chronic illnesses. These efforts laid the foundation for GRBM’s practical use in medicine and healthcare industries.
STEP 4
Bio substance development for advanced Life Re:Design (TBD) Research on Intermediate Mediator Materials involved in biological phenomena to establish a system for effectively managing Horizontal Gene Transfer. Based on this, the development of bio-substances to control life phenomena related to aging. To achieve this, an AI-based prediction model for plant-specific metabolites will be introduced.
Concept Development
Kim Sung-hoon
Former Minister of Agriculture and Forestry Acted as a mentor, guiding the foundational understanding of eco-friendly plant ecology.
Nam Sang-Min
Director of the UNESCAP Environment and Development Division
A mentor who instilled awareness about the 2005 Kyoto Protocol and biodiversity (2005~ )
Co-Chair of the UN Agency Network for Climate Goals
Technology Design
Professor Denis Noble
Systems Biologist
Renowned scholar who contributed to the conceptual development of Ecological Systems Biology through discussions at Stanford University (2013).
Professor Svante Pääbo,
Evolutionary Geneticist
Esteemed scholar who facilitated the conceptual development of Symbiotic Evolution and Genetic Interactions through discussions at the European Scholarly Conference (2015).
Clinical application
Dr. Jeon Se-il
Integrative Medicine Specialist
Medical advisor (2023~), providing counsel from an integrative perspective of Western medicine, Korean traditional medicine, and alternative medicine. Advisory focus on the role of miRNA.
Dr. Seo Woo-young
Diagnostic Medicine Specialist Medical advisor (2024~),
providing expertise in accurate patient condition diagnosis using advanced equipment. Advisory focus on the medical applications of miRNA.
